🌟 New! Concierge Care by Atrium 💙 Elevated. By Choice. 🌟
Peptides in 2026: What Works, What Doesn't, and Real Risks -- Atrium Medical NYC

PEPTIDE THERAPY: WHAT ACTUALLY WORKS, WHAT DOESN’T, AND WHAT PATIENTS SHOULD KNOW

PEPTIDE THERAPY: WHAT ACTUALLY WORKS, WHAT DOESN’T, AND WHAT PATIENTS SHOULD KNOW

Peptides are everywhere right now.

In February 2026, HHS Secretary Robert F. Kennedy Jr. announced that 14 peptides previously restricted by the FDA would be restored to legal compounding status. Overnight, the conversation moved from wellness TikTok into mainstream news. Patients started asking their doctors about BPC-157, CJC-1295, and Thymosin Alpha-1 — compounds most primary care physicians had never been asked about before.

This guide is not promotional. We’re an independent primary care practice in Midtown Manhattan on the leading edge of medicine, and our job is to help patients make sense of what’s actually going on.

Here’s what we know.

Short version: The GLP-1 medications — semaglutide, tirzepatide — are peptides. They are among the most rigorously studied drugs in modern medicine. Everything else being discussed right now sits somewhere on a spectrum from genuinely promising to completely unsubstantiated. This guide will help you figure out risks and the benefits so you can make an informed decision.


Add Comment